NeuroOne Medical Technologies Corporation (NMTC) vs Senti Biosciences, Inc. (SNTI)

A side-by-side comparison of NeuroOne Medical Technologies Corporation and Senti Biosciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — NMTC vs SNTI

growth of $100 · dividends reinvested · last 5y
NMTC -97.2% (-51.1%/yr)SNTI -99.7% (-67.8%/yr)NMTC compounded faster over this window
Log scale — wide-divergence pair
01101001kStart $10020222023202420252026$3$0
NMTC SNTI

NMTC vs SNTI: by the numbers

  • •SNTI is the larger company ($10M vs $10M market cap).
  • •Both run net losses; NMTC's is the smaller (-71.51% vs -90116.36% net margin).
  • •NMTC grew revenue faster over the past five years (37.21% vs -43.85% CAGR).

Metrics side by side

Valuation

MetricNMTCSNTI
P/S ratio0.98182.90
P/B ratio2.61N/A

Profitability

MetricNMTCSNTI
Gross margin67.30%-16431.82%
Operating margin-34.94%-289668.18%
Net margin-71.51%-90116.36%
ROE-189.76%N/A
ROIC-183.45%-227.67%

Growth (annualized)

MetricNMTCSNTI
Revenue CAGR (5Y)37.21%-43.85%
Total return CAGR (5Y)-46.02%-67.75%

Frequently asked

Which has grown faster, NMTC or SNTI?
Over the past five years, NMTC grew revenue faster — NMTC at a 37.21% CAGR versus SNTI at -43.85%.
How have NMTC and SNTI total returns compared?
Over the past 5 years, NMTC delivered -46.02% and SNTI delivered -67.75% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.